Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subcutaneous versus intravenous immunoglobulin in multifocal motor neuropathy
NL-OMON21709Not yet recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Jun 2007
- Modality
- Recombinant Proteins and Enzymes, Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Open-label, single-arm trial of Gamimune-N and immune globulin in multifocal motor neuropathy (MMN), sponsored by Amsterdam University Medical Center. Primary endpoint: Muscle strength maintenance. Planned start Jun 2007; status: not yet recruiting.
02
Drugs
Gamimune-Nimmune globulin
03
Conditions
multifocal motor neuropathy (MMN)
Beyond the preview
Go deeper on NL-OMON21709.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON21709.